Ingevity (NGVT) Q4 2024 earnings summary

Executive summary

• Proactive repositioning in 2024 improved performance, with record results in Performance Materials and enhanced shareholder value, while strategic alternatives were initiated for Industrial Specialties and North Charleston CTO Refinery.

• CEO transition occurred, with an interim CEO appointed and a permanent search ongoing.

• Advanced Polymer Technologies grew volume but faced margin pressure from adverse mix and price concessions.

• Aggressive repositioning actions led to ~$84 million in company-wide savings and improved Performance Chemicals margins in H2.

• Achieved top quartile safety performance and recognized as one of America's Most Responsible Companies for the third consecutive year.

Financial highlights

• FY 2024 net sales declined 17% to $1.4 billion, mainly due to a $300 million drop in Performance Chemicals sales from exiting lower margin markets.

• GAAP net loss of $430.3 million, reflecting $688 million in pre-tax charges, including $349.1 million goodwill impairment, restructuring, and contract termination fees.

• Adjusted EBITDA for FY was $362.7 million, margin 25.8%; Q4 adjusted EBITDA up 91% to $80.6 million, margin 27.0%.

• Adjusted gross profit was $521 million, down 4% year-over-year, but gross margin improved by 510 basis points.

• Free cash flow for FY was $51 million, despite $200 million in repositioning costs.

Outlook and guidance

• 2025 guidance: sales of $1.3–$1.4 billion, adjusted EBITDA of $400–$415 million, free cash flow of $220–$260 million, and net leverage below 2.8x.

• CapEx expected to be $50–$70 million, primarily for maintenance and safety.

• Full year 2025 tax rate projected at 22–24%.

• Performance Materials margins expected around 50% in 2025; APT margins around 20%; Performance Chemicals EBITDA margins in mid to high single-digits.

• Guidance excludes potential impacts from strategic alternatives for Industrial Specialties and North Charleston CTO refinery.